Abstract: The invention provides chimeric flavivirus vectors including foreign peptides inserted into the envelope proteins of the vectors and methods of using these vectors.
Type:
Grant
Filed:
May 31, 2002
Date of Patent:
August 4, 2009
Assignee:
Acambis Inc.
Inventors:
Harold Kleanthous, Charles Miller, Larisa Oros
Abstract: The invention provides chimeric flavivirus vaccines against West Nile virus and methods of using these vaccines to prevent or treat West Nile virus infection.
Type:
Grant
Filed:
November 17, 2003
Date of Patent:
March 24, 2009
Assignee:
Acambis Inc.
Inventors:
Juan Arroyo, Charles Miller, John Avram Catalan, Thomas P. Monath
Abstract: The invention provides recombinant flavivirus vaccines that can be used in the prevention and treatment of flavivirus infection. The vaccines of the invention contain recombinant flaviviruses including attenuating mutations.
Type:
Application
Filed:
April 24, 2006
Publication date:
July 24, 2008
Applicant:
Acambis Inc.
Inventors:
Konstantin V. Pugachev, Farshad Guirakhoo, Thomas P. Monath
Abstract: The invention provides attenuated Flavivirus vaccines, such as vaccines against Japanese encephalitis virus and West Nile virus, as well as methods of making and using these vaccines.
Type:
Application
Filed:
October 19, 2005
Publication date:
November 22, 2007
Applicant:
Acambis Inc.
Inventors:
Farshad Guirakhoo, Jian Liu, John Catalan, Thomas Monath, Konstantin Pugachev
Abstract: The invention provides active and passive immunization methods for preventing and treating Clostridium difficile infection, which involve percutaneous administration of C. difficile toxin-neutralizing polyclonal immune globulin, C. difficile toxoids, or combinations thereof. Also provided by the invention are C. difficile toxoids, C. difficile toxin-neutralizing polyclonal immune globulin, and methods of identifying subjects that produce C. difficile toxin-neutralizing polyclonal immune globulin.
Type:
Application
Filed:
May 30, 2007
Publication date:
October 4, 2007
Applicant:
Acambis Inc.
Inventors:
William Thomas, Paul Giannasca, Zhenxi Zhang, Wende Lei, Thomas Monath
Abstract: The invention provides attenuated vaccinia virus vaccines that can be used in methods to prevent or treat small pox in patients, as well as methods of obtaining such vaccines.
Abstract: The invention provides active and passive immunization methods for preventing and treating Clostridium difficile infection, which involve percutaneous administration of C. difficile toxin-neutralizing polyclonal immune globulin, C. difficile toxoids, or combinations thereof. Also provided by the invention are C. difficile toxoids, C. difficile toxin-neutralizing polyclonal immune globulin, and methods of identifying subjects that produce C. difficile toxin-neutralizing polyclonal immune globulin.
Type:
Grant
Filed:
December 16, 2003
Date of Patent:
November 29, 2005
Assignee:
Acambis Inc.
Inventors:
William D. Thomas, Jr., Paul J. Giannasca, Zhenxi Zhang, Wende Lei, Thomas P. Monath